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Introduction
            An estimated 80,000-100,000 radiofrequency ablation (RFA) procedures are performed
in the United States each year.1 Approximately 1% of these are performed on pediatric patients at
centers that contribute data to the Pediatric Radiofrequency Registry.2  Previous reports from this
registry have demonstrated that RFA can safely and effectively be performed in pediatric
patients.3,4  However, patients weighing less than 15 kg have been identified as being at greater
risk for complications.3,4 Consequently, there has been great reluctance to perform RFA in small
children such that children weighing less than 15 kg only represent approximately 6% of the
pediatric RFA experience2 despite the fact that this age group carries the highest incidence of
tachycardia, particularly supraventricular tachycardia (SVT).5   Factors other than the risk of
complications contribute to the lower incidence of RFA in this group, including the natural
history of the most common tachycardias (SVT), technical issues with RFA in small hearts, and
the potential unknown long-term effects of RF applications in the maturing myocardium. 
Conversely, there are several reasons why ablation may be desirable in small children, including
greater difficulties with medical management,6,7,8 the higher risk for hemodynamic compromise
during tachycardia in infants with congenital heart disease (CHD), and the inability of these
small children to effectively communicate their symptoms thereby making it more likely that
their symptoms may go unnoticed until the children become more seriously ill.   Before
ultimately deciding that catheter ablation is indicated in small children, one must consider which
tachycardias are likely to be ablated, the clinical presentation of these tachycardias, alternatives
to ablation, the relative potential for success or complications, and modifications of the
procedure that might reduce the risk of ablation in this group.
Tachycardia Substrates in Small Children
            It is necessary to have a clear understanding of which tachycardias that are likely to be
ablated in small children prior to adequately discussing whether or how to ablate them. 
Atrioventricular reciprocating tachycardia (AVRT) is the most common type of SVT in small
children9  with   a   prevalence   of   approximately  0.1-0.15%.10  AVRT,   AV   nodal   reentrant
tachycardia (AVNRT), and ectopic atrial tachycardia (EAT) respectively account for 80%, 5%,
and 15% of SVT in children less than 1 year of age and approximately 65%, 25%, and 10% of
SVT in children who are between 1 and 5 years.9 Atrial flutter (AF) is relatively uncommon in
this age group.  Congenital junctional ectopic tachycardia (JET) is rare.  However, JET can also
be uncommonly encountered in the small group of neonates who undergo neonatal surgery for
CHD.   Although the true prevalence of ventricular tachycardia (VT) in   small   children   is
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 5(1): 51-62 (2005)Andrew D. Blaufox “Catheter Ablation of Tachyarrhythmias in Small Children”                 52
unknown, it is felt to be relatively uncommon.  Thus far, the distribution of substrates ablated in
infants less than 1.5 years of age has been shown to be similar to the relative prevalence of the
tachycardias mentioned above (Figure 1).2   Since AVRT is the most likely tachycardia to be
encountered and ablated in small children, the remainder of this discussion will focus primarily,
but not exclusively, on AVRT with or without associated preexcitation.  
Figure 1. Distribution of substrates for infants (< 1.5 yrs) undergoing RFA. The
majority of infants who have undergone RFA have had an accessory pathway-
mediated tachycardia, such as AVRT.  The next most common substrate ablated was
EAT.  AVNRT, AF, JET, and VT were ablated in a similar number of patients. 
This distribution is similar to the distribution of substrates diagnosed in children of
this age.  AVNRT = atriventricular reciprocating tachycardia, EAT – ectopic atrial
tachycardia, AF = atrial flutter, JET = junctional ectopic tachycardia, VT =
ventricular tachycardia.  Data from reference 2.
Clinical Presentation of Tachycardias in Small Children
            There are few true “natural history” studies for tachycardias that present in childhood as
there has been a great propensity to treat once the problem has been identified.  However, several
important observations can be made with regard to the course of these tachycardias.  
            Approximately, 1/3-2/3 of patients who present with WPW or AVRT in infancy will not
have a recurrence of tachycardia after medication is discontinues at their first birthday.5,6  When
tachycardia does recur, it is usually well tolerated.  However, there are occasions when medical
intervention is not sought for a prolonged period of time resulting in hemodynamic collapse.11 
Mortality rates of approximately 5% have been reported in infants with WPW and AVRT.6,7 
While some of these deaths could be attributed to medication issues, it is likely that others were
do to hemodynamic collapse after the development of tachycardia-induced cardiomyopathy and
to cardiac arrest secondary to rapid ventricular conduction over the accessory pathway during
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atrial fibrillation in patients with WPW. Tachycardia-induced cardiomyopathy is a known
consequence of prolonged tachycardia in infants and needs to be distinguished from myocarditis
and recognized as a curable cause of cardiomyopathy12 The risk of sudden death in WPW is
approximately 0.1% per year overall and may be as high as 0.6% per year in “high risk”
patients.13  Klein et al originally reported the association between antegrade accessory pathway
conduction properties and ventricular fibrillation in patients with WPW.14   Although the
capability for a young child’s heart to sustain atrial fibrillation has been debated, sudden death
has been reported in the pediatric population and has been the presenting symptom in 2.3%.15 
The risk of sudden death in children with WPW has been associated a preexcited R-R interval of
190-220 msec during atrial fibrillation induced at EPS (sensitivity of 100% and a specificity of
72-74%).16 It is important to note that as the child ages, the conduction properties of the AV
node and the accessory pathway will also change, so that assessing risk is somewhat of a moving
target.  Despite this, the vast majority of patients with WPW and AVRT will not experience
severe symptoms.
            There has been less published on the natural history of other tachycardia substrates.  VT
has a higher likelihood of causing acute hemodynamic collapse.  While EAT is less likely to
cause acute hemodynamic compromise, its incessant nature increases the risk of developing
tachycardia-induced cardiomyopathy.  Any of these tachycardias are less likely to be tolerated in
children with structural heart disease.
  
Alternatives to Catheter Ablation
            There are three alternatives to catheter ablation.  These are not treating, treating with
drugs, and performing surgical ablation.  Surgical ablation is a precursor to catheter ablation and
is much more invasive so is rarely still performed today except in the form of an atrial maze
procedure being more commonly performed for more complex arrhythmias in older patients and
often with concurrent hemodynamic structural surgical intervention, thus it will not be discussed
further.  The other options are still practiced but are based on limited data.  
    
No Treatment
            The decision not to treat patients with WPW carries the potential risks of SVT recurrence
or sudden death.  The use of transesophageal pacing studies have been shown to have a negative
predictive value of 74-100% for predicting SVT recurrences.17,18  This method can also be used
to establish the likelihood of recurrent AVNRT or to determine the conduction properties of an
accessory pathway while assessing the risk of sudden death in children with WPW.  Thus, if the
patient is not at risk for sudden death and is not inducible, no treatment becomes an option. 
However, other factors must be considered, such as access to medical care and parent comfort
and abilities to handle recurrences.
            No treatment strategy for other arrhythmias is less established.
Medical Treatment
            Although there have been a great number of publications on the medical management of
tachycardias in small children, there have been no controlled studies.  Most studies report limited
success of drugs to control SVT.  Success rates for digoxin or beta-blockers have been reported
to be approximately 50% while success for the more toxic class I and class III agents are not
much better.18  Although various combinations may increase success, they also increase the
potential for side effects, particularly when class I and class III agents are combined. Reports of
more aggressive drug combinations have been limited to a very small number of patients and
thus their safety is essentially unknown.  It is clear, however, that drug therapy, whether given as
single agent or in combination, has the potential for adverse reactions including death.15   While
most drug therapies will be well tolerated, the lack of controlled data delineating their efficacy,
makes balancing the risk/benefit ratio for drug therapy difficult.   Another point about drug
therapy is that it is unlikely to protect one against rapid conduction during atrial fibrillation in
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patients with WPW unless they are being treated with class I or class III drugs.
RF Ablation
Success
            Several studies on RFA in children have shown that there is no difference in success rate
in small children for eliminating arrhythmias on the whole or AVRT in comparison to older
children.2,3,4  The comparable success rates may be partially due to the fact that ablations in
smaller   children   are   more   likely   to   be   attempted   by   more   experienced   pediatric
electrophysiologists2 and experience has been shown to be an important factor in  successful
pediatric RFA procedures.19  Although pediatric ablation registry studies involving the entire
pediatric age span have found lower success rates in children with structural heart disease,3,4 
substrate elimination in infants has been shown not to be influenced by the presence of structural
heart disease.2  Thus, beliefs that RFA will be less successful for infants with heart disease are
incorrect and should not deter attempts in those infants in whom RFA is indicated.  Another
interesting difference between infants and older children is that infant accessory pathway
elimination may not necessarily be related to AP location.2,4  Similar to reports in adult, the
presence of multiple accessory pathways in infants is associated with lower success rates.    
Complications
Overall
               As stated previously, children weighing less than 15 kg have been shown to be at
increased risk for complications during RFA.3,4   In Blaufox et al.’s pediatric ablation registry
study of infants less than 1.5 years of age, a higher complication rate was found in infants in
comparison to older children, but power limitations may have prevented the difference from
reaching statistical significance.2   When data from 231 registry patients weighing < 15 kg but
being > 1.5 years old were factored in to the analysis, this study did confirm a higher
complication rate in children < 15 kg.  However, there was no appreciable difference in major
complications for the infants less than 1.5 years of age.
            Typically, RF lesions made in vivo, vary in size from non-existent to 5 or 6 mm radius.
The average adult heart has a wall thickness of 3-12 mm’s.  However, the size of the heart and its
internal structures are proportional to body size.20 Consequently, the theoretical risk of injuring
cardiac structures in small children is higher and might depend specifically on the parameters
that influence lesion size. In controlled animal studies, RF lesion size is directly related to
catheter tip size, RF power, tip temperature and lesion duration.21 Further, more RF applications
is clearly more likely to increase total lesion volume.   Similarly, repeated thermal injury in
nearby areas can be expected to increase the chance of injury to adjacent vital structures, again
with an inverse relation to patient size.  Finally, the scars created by RF energy have a greater
chance of expanding into vital structures when the myocardium is less mature.22  As the greatest
increase in heart size and maturity occurs during the neonatal and infant ages, disparities in size
and myocardial maturity appear to be important even within the subgroup of small children.
            The major complications in small children include pericardial effusion, pneumothorax,
AV block, and death.2  In addition to these complications, small children may be at particular
risk for coronary artery injury.
Death
            The overall mortality associated with pediatric RFA has been reported by Schaffer et al.
as 0.12%.23 This study contained the report of an infant with a structurally normal heart who died
2 weeks following RFA for AVRT.  Approximately 111 RFA procedures were done infants
during the period covered by Schaffer et al yielding an infant mortality of approximately 0.9%. 
In addition, Schaffer’s study reports the death of an 18 month old child with congenital heart
disease who underwent RFA and died the following day with fever and hypotension, but in
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whom no link between death and RFA could clearly be established.   Blaufox et al reported the
acute death of a separate infant yielding an infant mortality of 0.74% in that study.   The
discrepancy between Schaffer et al. is due to the difference in time periods covered by 2 studies
and the fact that the Blaufox et al. report represented only acute results while the Schaffer et al.
report included follow up.   Although each report only includes one instance of death and thus
the actual incidence might be somewhat inaccurate, it is evident that death can result from infant
RFA. 
AV Block
            Body weight less than 15 kg is an independent risk factor for AV block during RFA.4
Similar to reports in older children,4 RFA for septal AP’s in infants is also associated with a
higher incidence of heart block.2  Thus, the ablation of septal substrates in small children is
particularly risky.  This is not surprising if one considers the relative sizes of RF lesions and the
triangle of Koch in children.  As stated previously, RF lesions generally have a radius of 5-6mm. 
Unlike in adults, the dimensions of the Triangle of Koch are proportional to body size in children
(Figure 2).24  Therefore, a lesion with a fixed size will have a greater likelihood of injuring vital
structures within and around the triangle of a smaller child.   So, great caution must be used
when approaching these substrates.  
Figure 2. Dimensions of the Triangle of Koch  This drawing illustrates the
relative dimensions of Koch’s Triangle in children.  Each side and the area of the
triangle are proportional to body size according to the formulas shown.  CFB =
central fibrous body, CS = coronary sinus, TVA = tricuspid valve annulus, ToK =
Triangle of Koch, ToT = Tendon of Todaro, A = Triangle of Koch area.  Data
from reference 24.
Coronary Injury
            Coronary artery injury during RFA is a rare, but serious event25 that has occasionally
produced death23,26.  Nearly all of the reports of coronary artery injury following RFA have been
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single case reports that have involved accessory pathway elimination.  Of the 5 deaths in children
with structurally normal hearts reported by the pediatric ablation registry,23 1 was the result of
thermal injury to the left main coronary artery and subsequent thrombosis of that vessel in a 13
year old child who underwent RFA for AVRT.  In addition to these reports involving accessory
pathways, there has been one report of injury to the posterior left ventricular branch artery during
slow pathway ablation for AVNRT in a 15.5 kg child.27
            The mechanism of coronary injury is likely to be a combination of direct thermal injury
and subsequent inflammatory response.  The inflammatory component of tissue injury caused by
RF energy has been shown to invade layers of the right coronary artery, leading to acute
narrowing when RF energy is applied to the atrial side of the lateral tricuspid annulus in pigs.28 
Further maturation of this injury can result in significant late coronary stenosis.29  Thus, with RF
energy application, coronary stenosis may occur acutely or may be delayed.  
            In addition to the potential for coronary injury to be delayed, it may also be subtle, thus it
may go unrecognized so that the incidence of sub-clinical coronary injury is likely to be
underestimated. Blaufox et al. presented a patient in whom coronary injury was nearly missed
because ST segment changes did not occur until 100 seconds after the last RF application and
resolved spontaneously within minutes despite a significant persistent stenosis of the posterior
left ventricular branch coronary artery.27  In large retrospective and prospective studies where
there were no coordinated attempts to investigate coronary injury after RFA, the reported
incidences of injury were 0.03% in children4, and 0.06-0.1% in adults.30  However, in a study
where coronary angiography was performed before and after RFA for accessory pathway-
mediated tachycardias, Solomon et al reported a 1.3% incidence of coronary artery injury in 70
patients following RFA for accessory pathway-mediated tachycardias.31 Thus, unless evidence
for coronary artery injury is actively sought, it may go undiagnosed and underreported.  With the
exception of severe stenoses, injury may go unrecognized until premature coronary disease
becomes associated with people who have undergone RFA as young children.
Modifications
            Modifications to the standard RFA procedure, such as, the use of smaller caliber catheters
with smaller tips, the use of 5-second applications with lower temperature set points to test
location accuracy, and the limitation of full applications to 20 seconds have been proposed and
implemented.32,33  Although these modifications are based upon physical and animal studies of
the effects of radiofrequency energy on the maturing myocardium, aside from limiting the
number of RF applications, which has been shown to decrease mortality,23 little clinical data
exists to support these modifications in the application of RFA in small children2,11,32,33. 
However, for AVRT, Blaufox et al reported that the relationship between complications and
application number and duration holds up for applications with durations greater than 20 seconds
only when the number of these applications is indexed to body weight in kg (Figure 3).34  In
other words, the increase in risk of giving applications with a duration > 20 seconds was
proportional to the patient’s weight.  Inherent in the idea of limiting the number of lesions, is the
abstention from giving an “insurance” lesion.  In addition to limiting the length and number of
applications based upon the patients size, perhaps the most important modification proposed in
this study is the lowering of one’s threshold for accepting failure, for numerous studies have
shown that a greater number of lesions will be given during a failed procedure in comparison to a
successful one.2
Alternative Energy 
            An alternate strategy for catheter ablation is to find an energy source that may be safer
than RFA in small children.   Although there have been no trials of cryoablation in small
children, there are several aspects to this technology that make it a potential alternative.  The
results of prior animal studies suggest that some advantages of cryo-therapy may be particularly
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important for children.  Cryo-ablation sites are histologically well delineated, discrete, and show
homogeneous dense fibrous tissue without viable myocardium interspersed.35  Cryo-lesions are
smaller than RFA lesions,36 contributing to the ability to safely create cryo-lesions even adjacent
to the His bundle.  In addition,  both  cryoablation  allows  for  reversible  loss  of  tissue
function.37,38  These transient effects occur for both the normal AV conduction fibers and the
targeted tachycardia substrate.   Friedman et al.38  also reported 12 instances of transient AV
block, 11 of which occurred during cryo-ablation modes, and all of them resolved completely. 
Because the leading edge of the ice ball during cryo-therapy is by definition near 0 oC and
warmer than the temperature measured at the catheter tip, it is likely that discontinuation of cryo-
therapy at the first signs of an electrophysiological effect will reverse that effect.   Another
potential safety feature of cryo-therapy is catheter stability at the point of tissue freeze.  This lack
of tip movement should both improve success when the catheter is in the correct place, and
prevent lesion spread to undesirable locations through the sliding movement seen with RFA.  
Figure 3. Relationship between RF lesions, weight and complications.  This
graph shows a higher likelihood of complications when the ratio between RF
lesions (duration > 20 seconds) and body weight increases.  The formula y = 0.27x
is the trend line for this ratio in patients without complications.  Although the data
is based upon a few patients and has not been formally tested, it illustrates the
main general message to limit RF lesion number and duration based upon patient
weight.  Data from reference 11.
            Because cryo-lesions are more delineated and smaller than RF lesions, cryoablation may
require more precise positioning, particularly for the relatively discrete accessory pathways. 
Therefore it is not surprising that the acute success rate may be lower.  Friedman et al reported an
overall success rate of 69% for AVRT in adults.38  However, success rates for septal accessory
pathways and AVNRT were more comparable to those with RF ablation.38   There is limited data
with cryoablation in children, but our own experience with cryoablation in pediatric patients
supports the data found in adults.  We have experienced success rates of 96% for AVNRT and
63% for AVRT without any major complications. All instances of AV block have been transient
with full recovery within a few seconds. Although our experience is limited, given the potential
safety advantages for this technology, it is reasonable to consider using it prior to RF ablation in
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small children despite the lower expectations for success.
Indications
            Infants who have undergone RFA have done so for indications that are different than
those for older children in whom RFA is done for “patient choice” 51% of the time. (Figure 4).
2   The differences in indications between infants and older children demonstrate that infants are
sicker upon presentation and perceived to be at greater risk during arrhythmia.   Although these
perceptions are heightened for infants with structural heart disease and there is a higher incidence
of structural heart disease for infants undergoing RFA, the incidence of structural heart disease
does not entirely account for these perceptions because they are still true for infants with
structurally normal hearts.2 
Figure 4. Distribution of indications for infants undergoing RFA as reported
from  the Pediatric Radiofrequency  Ablation  Registry.  Infants who  have
undergone RFA have done so because they have been perceived to be at greater
risk from their arrhythmia or more difficult to treat.  This is in contrast to older
children in whom RFA has been done for “patient choice” 51 % on the time (data
not shown). Data from reference 2.
            Because the definition of indications reported from the pediatric RFA registry, such as
refractory to medical therapy, vary widely from center to center, others have sought to establish
more clear cut indications.  In 2002, a position statement was published by members of the
Pediatric Electrophysiology Society and endorsed by the North American Society of Pacing and
Electrophysiology. (Friedman RA NASPE)   Class I  indications, in which there is clear and
consistent agreement that RFA will benefit the patient, included:1) WPW following aborted
sudden death, 2) WPW and syncope with a shortest prexcited R-R < 250 msec, 3) chronic or
recurrent SVT with ventricular dysfunction, 4) and recurrent VT associated with hemodynamic
compromise and is amenable to RFA. Class IIA indications, in which the majority of opinion or
data favor RFA, include 1) recurrent and/or symptomatic SVT refractory to medical therapy and
age > 4 years, 2) impending congenital heart surgery when vascular or chamber access may be
limited following surgery, 3) chronic (>6 months) or incessant tachycardia with normal
ventricular function, 4) chronic or frequent recurrences of intraatrial reentrant tachycardia, and 5)
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palpitations with inducible SVT during EPS.  Class IIB indications, in which there is a clear
divergence of opinion regarding the need RFA, include: 1) asymptomatic WPW and age > 5yrs
when the risk/benefits of RFA have been explained to the family, 2) SVT, age > 5 yrs, as an
alternative to chronic medical therapy that has controlled the tachycardia, 3) SVT, age < 5 yrs,
when medications, including sotalol and amiodarone, have not controlled the tachycardia or have
resulted in intolerable side effects, 4) intraatrial reentrant tachycardia, 1-3 episodes per year
requiring medical intervention, 5) AV node ablation for intratrial reentrant tachycardia, 6) one
episode of VT with hemodynamic compromise and amenable to RFA.  Class III indications, in
which there is agreement that RFA is not indicated, include: 1) asymptomatic WPW, age < 5 yrs,
2) SVT, controlled with medication, age < 5 yrs, 3) Nonsustained and non incessant VT without
ventricular dysfunction, 4) Nonsustained, asymptomatic SVT.
    
Conclusion
               Catheter ablation in small children should be reserved for truly life threatening or
refractory arrhythmias after multiple failed attempts at medical management, which may include
various   combination   therapies.   RFA   should   be   performed   by  an   experienced   pediatric
electrophysiologist who undertakes various strategies to reduce risk, including limiting power
and temperature as well as application duration and attempts based upon the patient’s size.
Consideration of the use of alternate sources of energy like cryoablation prior to RFA may be
helpful.  Despite a high potential for success, having a lower threshold for accepting failure is
essential.
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